Eric Chang, MD, FASTRO

Keck School of Medicine of USC

Disclosure:
Employment
Keck School of Medicine of USC: Professor and Chair: Employee

Compensation
AbbVie: Honoraria

Leadership
ASCO: Track Member

Biography:
Eric L. Chang, MD, FASTRO is Professor and Chair of Radiation Oncology at the Keck School of Medicine of USC. He is considered a world authority in the use of radiation therapy in the treatment of benign conditions and malignant tumors of the central nervous system.
Prior to joining USC, he was on the faculty as an attending radiation oncologist at The University of Texas M. D. Anderson Cancer Center for over 12 years, rising to an academic rank of Professor. Having established the first Gamma Knife radiosurgery program at M. D. Anderson, he served as the Director of the CNS Stereotactic Radiation Program comprising the Gamma Knife program, and the Stereotactic Body Radiation Therapy (SBRT) program for spine. He is board certified by the American Board of Radiology in radiation oncology and specializes in the radiotherapeutic evaluation and management of patients with tumors of the central nervous system. He attended Harvard Medical School where he received his Doctorate in Medicine. His post-graduate training was conducted at the Harvard Joint Center for Radiation Therapy.
He has held research leadership roles including having served as member, and Chair of the M. D. Anderson Cancer Center Clinical Research Committee (CRC). He has served as both CNS track leaders for the American Society for Clinical Oncology (ASCO) Scientific Program Committee, and ASCO Cancer Education Committee. He is the current chair of the American Radium Society Appropriate Use Committee (AUC) for brain. Dr. Chang led a phase III randomized controlled trial on brain metastasis published in the Lancet Oncology 2009 which has helped to change the practice patterns for metastatic brain disease. He has authored or co-authored over 100 peer-reviewed papers and abstracts. He is the lead editor for a new major textbook on Adult CNS Radiation Oncology published in 2018 by Springer.

Presentation(s):

Indications for WBRT vs. SRS in the Management of Multiple Brain Metastases
Sunday, October 21
1:15 PM – 1:35 PM
Meet the Expert - Central Nervous System
Sunday, October 21
4:15 PM – 4:35 PM
SS 09 - Patient Reported Outcomes/Quality of Life/Survivorship
Monday, October 22
7:45 AM – 9:00 AM

Send Email for Eric Chang

Subject

Body

<h1>  shared a speaker with you!</h1><div><b>Name:</b> Eric Chang</div><div><b>Organization:</b> Keck School of Medicine of USC</div><div><b>Position:</b> Not Available</div><div><b>Bio:</b> Eric L. Chang, MD, FASTRO is Professor and Chair of Radiation Oncology at the Keck School of Medicine of USC.  He is considered a world authority in the use of radiation therapy in the treatment of benign conditions and malignant tumors of the central nervous system.
Prior to joining USC, he was on the faculty as an attending radiation oncologist at The University of Texas M. D. Anderson Cancer Center for over 12 years, rising to an academic rank of Professor. Having established the first Gamma Knife radiosurgery program at M. D. Anderson, he served as the Director of the CNS Stereotactic Radiation Program comprising the Gamma Knife program, and the Stereotactic Body Radiation Therapy (SBRT) program for spine. He is board certified by the American Board of Radiology in radiation oncology and specializes in the radiotherapeutic evaluation and management of patients with tumors of the central nervous system. He attended Harvard Medical School where he received his Doctorate in Medicine.  His post-graduate training was conducted at the Harvard Joint Center for Radiation Therapy.  
He has held research leadership roles including having served as member, and Chair of the M. D. Anderson Cancer Center Clinical Research Committee (CRC). He has served as both CNS track leaders for the American Society for Clinical Oncology (ASCO) Scientific Program Committee, and ASCO Cancer Education Committee.  He is the current chair of the American Radium Society Appropriate Use Committee (AUC) for brain. Dr. Chang led a phase III randomized controlled trial on brain metastasis published in the Lancet Oncology 2009 which has helped to change the practice patterns for metastatic brain disease. He has authored or co-authored over 100 peer-reviewed papers and abstracts. He is the lead editor for a new major textbook on Adult CNS Radiation Oncology published in 2018 by Springer.
</div>